Questions have been raised about how Australia ensures the quality of its imported medicines after a major pharmaceutical ...

The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

Sun Pharma plans to submit a new drug application for the alopecia candidate to the FDA in the first half of 2023.

The Indian-based pharma company stated that it expects the deal to be completed during the first quarter of 2023.

A Boca Raton pharmaceutical company has agreed to settle charges with the Food and Drug Administration that allege improper ...

The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including its failure to follow appropriate written procedures designed to prevent microbiological contamination ...

An import alert may follow a warning letter or OAI classification if the FDA is not satisfied with ... subject to the exemption of certain products. Sun Pharmaceutical Industries' Halol facility ...

Concert Pharmaceuticals and its alopecia drug have found a new home. Mumbai-based Sun Pharma announced early Thursday that it ...

Sun Pharmaceutical Industries Ltd. shares inched down 0.10% to 1,039.95 Indian rupees Wednesday, on what proved to be an ...

Sun Pharmaceutical Industries has announced that one of its wholly-owned subsidiaries has launched a novel anti-cancer drug, Palbociclib, in India for patients who have advanced breast cancer ...

(Reuters) -Sun Pharmaceutical Industries Limited said on Thursday it will acquire U.S.-based Concert Pharmaceuticals for $576 ...